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Abstract
The poor regenerative capacity of descending neurons is one of the main causes of the lack of recovery after spinal
cord injury (SCI). Thus, it is of crucial importance to ﬁnd ways to promote axonal regeneration. In addition, the
prevention of retrograde degeneration leading to the atrophy/death of descending neurons is an obvious prerequisite
to activate axonal regeneration. Lampreys show an amazing regenerative capacity after SCI. Recent histological work in
lampreys suggested that GABA, which is massively released after a SCI, could promote the survival of descending
neurons. Here, we aimed to study if GABA, acting through GABAB receptors, promotes the survival and axonal
regeneration of descending neurons of larval sea lampreys after a complete SCI. First, we used in situ hybridization to
conﬁrm that identiﬁable descending neurons of late-stage larvae express the gabab1 subunit of the GABAB receptor.
We also observed an acute increase in the expression of this subunit in descending neurons after SCI, which further
supported the possible role of GABA and GABAB receptors in promoting the survival and regeneration of these
neurons. So, we performed gain and loss of function experiments to conﬁrm this hypothesis. Treatments with GABA
and baclofen (GABAB agonist) signiﬁcantly reduced caspase activation in descending neurons 2 weeks after a
complete SCI. Long-term treatments with GABOB (a GABA analogue) and baclofen signiﬁcantly promoted axonal
regeneration of descending neurons after SCI. These data indicate that GABAergic signalling through GABAB receptors
promotes the survival and regeneration of descending neurons after SCI. Finally, we used morpholinos against the
gabab1 subunit to knockdown the expression of the GABAB receptor in descending neurons. Long-term morpholino
treatments caused a signiﬁcant inhibition of axonal regeneration. This shows that endogenous GABA promotes axonal
regeneration after a complete SCI in lampreys by activating GABAB receptors.
Introduction
In contrast to mammals, lampreys show spontaneous
and successful functional recovery after a complete spinal
cord injury (SCI) and this is in part due to their impressive
ability for axonal regeneration1–8. But, even in lampreys,
not all descending neurons of the brain are able to
regenerate their axons through the site of injury after a
complete spinal cord transection4,9–12. The lamprey
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brainstem contains approximately 30 large individually
identiﬁable descending reticulospinal neurons that vary
greatly in their ability for axonal regeneration after SCI,
even when their axons run in similar paths in a spinal
cord that is permissive for axonal regrowth4,12,13. Some
identiﬁable descending neurons of lampreys are con-
sidered “good regenerators” (i.e. they regenerate their
axon more than 55% of the times; the I3, I4, I5, B2, B5 and
B6 neurons) and others are considered “bad regenerators”
(i.e. they regenerate their axon less than 50% of the times;
the M1, M2, M3, I1, I2, B1, B3, B4 and Mth neurons)4,6,12.
This indicates that interactions with the extrinsic spinal
cord environment and intrinsic differences between des-
cending neurons affect their regenerative abilities after
SCI. Recent work has also shown that identiﬁable des-
cending neurons of lampreys that are known to be “bad
regenerators” slowly die after a complete SCI and are also
“poor survivors”12,14,15. The death of these neurons after
SCI appears to be apoptotic as indicated by the appear-
ance of TUNEL labelling and activated caspases in their
soma14–18. This offers a convenient vertebrate model to
study the inhibition or promotion of neuronal survival
and axonal regeneration in the same in vivo preparation
and at the level of single neurons.
In mammals, SCI leads to a massive release of aminoa-
cidergic neurotransmitters (glycine and GABA:19,20; gluta-
mate:21–23). Excessive glutamate release after SCI is
responsible for excitotoxicity and neuronal death21,22. High
extracellular glutamate levels result in excessive activation
of glutamate receptors, triggering massive Ca2+ inﬂux into
cells, which leads to neuronal death24. Extracellular glycine
could also contribute to glutamate excitotoxicity20, since it
is a co-agonist of the N-methyl-D-aspartate glutamate
receptor25. The phenomenon of excitotoxicity has been
mainly studied in intrinsic spinal cord cells; however, ret-
rograde damage to neurons is also likely due to the fact that
Ca2+ ions gain access to the axoplasm of damaged axons26.
In contrast to glutamate, it has been reported that GABA
could have neuroprotective effects after different types of
central nervous system (CNS) damage27–31. The activation
of pre-synaptic GABAB receptors causes inactivation of
voltage-dependent Ca2+ channels (see32), which could
prevent the inﬂux of Ca2+ ions due to glutamate release. In
addition, it has been shown that GABA can modulate and
promote neurite outgrowth in vitro or during development
(for reviews see33,34). However, a role for GABA and
GABAB receptors in neuroprotection and especially in
axonal regeneration after SCI has not been reported yet.
In lampreys, glutamate induces an inhibition of neurite
outgrowth in reticulospinal neurons in vitro due to Ca2+
inﬂux35. Electrophysiological studies have also suggested
that low intracellular Ca2+ levels due to downregulation of
Ca2+ channels could facilitate axonal regeneration in axo-
tomized descending neurons of lampreys36. More recently,
we have reported that, as in mammals, there is a massive
release of glutamate, GABA and glycine from most spinal
cord neurons close to the lesion site following a complete
SCI37–39. Between 1 and 3 days after the injury, we observed
the extracellular accumulation of GABA in the form of
“halos” around some axotomized axons of descending
neurons close to the site of injury. Statistical analyses
revealed a signiﬁcant correlation between GABA accumu-
lation and a higher survival ability of the corresponding
identiﬁable descending neurons37. An electrophysiological
study in the spinal cord of lampreys has also found a cor-
relation between higher GABAergic inhibition and a better
recovery of function in spinal lesioned animals40. These
data prompted us to hypothesize that, in lampreys,
increased GABA signalling after SCI could be favouring the
recovery process by promoting survival and axonal regen-
eration of descending neurons. Here, we address this
question for the ﬁrst time in vivo in any vertebrate and
provide gain and loss of function evidence showing that
endogenous GABA, acting through GABAB receptors,
promotes survival and axonal regeneration of identiﬁable
descending neurons after SCI in lampreys.
Materials and methods
Animals
All experiments involving animals were approved by the
Bioethics Committee at the University of Santiago de
Compostela and the Consellería do Medio Rural e do Mar
of the Xunta de Galicia (License reference JLPV/IId; Gali-
cia, Spain) or the Institutional Animal Care and Use
Committee at the Marine Biological Laboratory (Woods
Hole, MA) and were performed in accordance to European
Union and Spanish guidelines on animal care and experi-
mentation or the National Institutes of Health, respectively.
During experimental procedures, special effort was taken to
minimize animal suffering and to reduce the use of animals.
Animals were deeply anaesthetized with 0.1% MS-222
(Sigma, St. Louis, MO) in lamprey Ringer solution before all
experimental procedures and euthanized by decapitation at
the end of the experiments.
Mature and developmentally stable larval sea lampreys,
Petromyzon marinus L. (n= 115; between 95 and 120mm
in body length, 5 to 7 years of age), were used in the study.
Larval lampreys were collected from the river Ulla (Galicia,
Spain), with permission from the Xunta de Galicia, or
provided by Lamprey Services, Inc. (Ludington, MI, USA)
and maintained in aerated fresh water aquaria at 15–23 °C
with a bed of river sediment until their use in experimental
procedures. Lampreys were randomly distributed between
the different experimental groups.
SCI surgical procedures
Animals were assigned to the following experimental
groups: control unlesioned animals or animals with a
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complete spinal cord transection that were analyzed
1 week post-lesion (wpl), 2 wpl, 4 wpl, 10 wpl or 12 wpl.
Within the 2, 10 and 12 wpl groups, the injured animals
were assigned to either control or treatment groups.
Table 1 summarizes the number of animals assigned to
each experimental group and condition. Each experiment
was carried out in at least two different batches of ani-
mals. Complete spinal cord transections were performed
as previously described41. Brieﬂy, the rostral spinal cord
was exposed from the dorsal midline at the level of the 5th
gill by making a longitudinal incision with a scalpel (#11).
A complete spinal cord transection was performed with
Castroviejo scissors and the spinal cord cut ends were
visualized under the stereomicroscope. After spinal
transections, the animals were returned to fresh water
tanks and each transected animal was examined 24 h after
surgery to conﬁrm that there was no movement caudal to
the lesion site. Then, the animals were allowed to
recover in individual fresh water tanks at 19.5 °C and in
the dark.
In situ hybridization
For gabab1 in situ hybridization, the head of the animals
was ﬁxed by immersion in 4% paraformaldehyde (PFA) in
0.05M Tris-buffered saline (TBS; pH 7.4) for 12 h. Then,
the brains were dissected out, washed and embedded in
Neg 50TM (Microm International GmbH, Walldorf, Ger-
many), frozen in liquid nitrogen-cooled isopentane, sec-
tioned on a cryostat in the transverse plane (14 μm thick)
and mounted on Superfrost Plus glass slides (Menzel,
Braunschweig, Germany). In situ hybridization with a spe-
ciﬁc riboprobe for the gabab1 subunit of the sea lamprey
gabab receptor (GenBank accession number KX655780; see
Suppl. Figure 1) was conducted as previously described42.
Brieﬂy, brain sections were incubated with the sea lamprey
gabab1 DIG-labelled probe at 70 °C and treated with RNAse
A (Invitrogen, Massachusetts, USA) in the post-
hybridization washes. Then, the sections were incubated
with a sheep anti-DIG antibody conjugated to alkaline
phosphatase (1:2000; Roche, Mannhein, Germany) over-
night. Staining was conducted in BM Purple (Roche) at 37 °
C. In situ hybridization experiments were performed in
parallel with animals from the different experimental
groups (control, 1 wpl, 2 wpl and 4 wpl) and the colori-
metric reaction was stopped simultaneously for all sections
from the different groups of animals.
Drug treatments
The following drugs were used to treat the animals
following the complete spinal cord transection: GABA
Table 1 Table showing the number of animals included in each experimental group and also the total number of
identiﬁable descending neurons that were included in the analyses
Animals Total number of neurons included in the analyses
M1 M2 M3 I1 I2 I3 I4 I5 B1 B2 B3 B4 B5 B6 Mth
Changes in gabab1 expression Control 7 11 11 12 8 – 5 8 5 9 – 10 9 – 7 9
1 wpl 7 10 10 14 12 – 12 9 6 9 – 13 9 – 11 14
4 wpl 6 10 12 12 9 – 6 6 6 5 – 6 5 – 5 7
GABA treatment (2 wpl) Control 6* 11 11 10 12 9 11 12 7 12 11 12 12 11 12 12
Treated 5 6 8 8 9 6 9 9 5 10 10 10 10 7 9 10
Baclofen treatment (caspase activation, 2 wpl) Control 7* 13 12 11 14 9 13 14 8 14 13 14 14 12 14 14
Treated 7 12 13 13 14 7 14 13 6 14 13 14 14 13 13 13
GABOB treatment (12 wpl) Control 15 30 30 29 29 24 30 30 29 30 30 30 30 30 30 30
Treated 14 26 25 24 28 24 28 27 28 25 24 26 28 23 28 24
Baclofen treatment (axonal regeneration, 12 wpl) Control 7 12 12 13 14 12 14 14 11 14 12 14 14 14 12 13
Treated 11 21 21 21 22 19 22 22 21 22 22 22 22 22 22 22
Gabab1 morpholino (ISH, 2 wpl) Control 3 6 – – 6 – – – – – – – – – – –
Treated 4 7 – – 8 – – – – – – – – – – –
Gabab1 morpholino (axonal regeneration, 10 wpl) Control 9 18 18 18 18 18 18 18 18 18 18 18 18 18 18 18
Treated 13 26 26 26 25 26 26 26 26 26 26 26 26 26 26 26
Total 115
Please note that in the in situ hybridization experiments, only the neurons that were unequivocally identiﬁed in at least two brain sections were included in the
quantiﬁcations. In the FLICA experiments, six animals were used as controls for both the GABA and baclofen treatments and an extra animal was used as a control only
for the baclofen treatment (asterisks)
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(Sigma; Cat#: A2129; MW: 103.12 g/mol), GABOB (a
GABA analogue; Sigma; Cat#: A56655; MW: 119.12 g/
mol) and baclofen (a GABAB receptor agonist). Baclofen
was acquired from two different companies: for the
experiments of caspase activation, we used baclofen from
Molekula (Newcastle, UK; Cat#: 31184509; MW: 213.66
g/mol), and for the experiments of axonal regeneration,
we used baclofen from Carbosynth (Berkshire, UK; Cat#:
FB18127; MW: 213.66 g/mol). The drugs were applied in
the water where the animals were left after the SCI sur-
gical procedures (GABA at a concentration of 500 µM,
GABOB at a concentration of 50 µM and baclofen at a
concentration of 125 µM). The concentrations of baclofen
and GABA were selected based on previous in vitro
electrophysiological studies in lampreys43. Since GABA
does not easily cross the blood–brain barrier, it was
applied at a high concentration and only in the ﬁrst days
after the injury when the spinal cord is still disrupted. We
assumed that GABOB and baclofen also cross the
blood–brain barrier as in mammals, since the
blood–brain barrier of lampreys is similar to that of
higher vertebrates44,45. While we do not know the ﬁnal
concentration of the drugs in the CNS, we were conﬁdent
that this application route allows access to the CNS as
there were changes in the swimming behaviour of unle-
sioned animals in pilot experiments using baclofen and
GABOB at these concentrations (not shown). Since these
drugs are water soluble, control lesioned and non-treated
animals were left in fresh water only. The animals that
were analyzed for caspase activation 2 wpl were treated
with GABA or baclofen during 4 days from the day of
injury and replacing the drug and water every day during
those 4 days. The animals that were analyzed for axonal
regeneration 12 wpl were treated with GABOB or baclo-
fen during the 12 weeks replacing the drug and the water
four times each week. The animals were always kept in the
dark during the drug treatments to prevent light degra-
dation of these drugs.
Morpholino treatment
Application of morpholinos was performed as pre-
viously described in ref.13. Brieﬂy, the spinal cord was
transected at the level of the 5th gill (see surgical proce-
dures), and morpholinos (20 µg in lamprey internal
solution: 180 mM KCl, 10 mM HEPES, pH 7.4; designed
by GeneTools, LLC; Philomath, OR) were added at the
time and site of SCI soaked in a small piece of Gelfoam
(Pﬁzer; New York, NY). These included an active splicing-
blocking gabab1 morpholino (5′-ACGTCTGCAACG-
GAGAGTCATGAGA-3′) generated against the boundary
between the second intron and the second exon of the
partial sea lamprey gabab1 sequence (Suppl. Figure 1),
and a 5-base pair mismatch gabab1 negative control
morpholino (5′-ACcTCTcCAACcGAGAcTCATcAGA-
3′). During recovery, the morpholinos are retrogradely
transported to the cell soma of descending neurons where
they can knockdown the expression of the target
mRNA13,46–48. Animals were allowed to recover for 10
wpl to analyze the effect of gabab1 knockdown (KD) in
axonal regeneration of identiﬁable descending neurons. In
situ hybridization was used to control the efﬁcacy of the
gabab1 morpholino KD in animals processed at 2 wpl.
Detection of activated caspases in whole-mounted brain
preparations
The Image-iT LIVE Green Poly Caspases Detection Kit
(Cat. No. I35104, Invitrogen, USA) was used to detect
activated caspases in identiﬁable descending neurons (the
M1, M2, M3, I1, I2, I3, I4, I5, B1, B2, B3, B4, B5, B6 and
Mth neurons; see Suppl. Figure 2A) of larval sea lampreys
2 weeks after the complete spinal cord transection and the
GABA or baclofen treatments. This kit contains 1 vial
(component A of the kit) of the lyophilized FLICA reagent
(FAM–VAD–FMK). The reagent associates a ﬂuor-
omethyl ketone (FMK) moiety, which can react covalently
with a cysteine, with a caspase-speciﬁc aminoacid
sequence (valine–alanine–aspartic acid (VAD)). A car-
boxyﬂuorescein group (FAM) is attached as a ﬂuorescent
reporter. The FLICA reagent interacts with the enzyme
active centre of an activated caspase via the recognition
sequence, and then attaches covalently through the FMK
moiety. Experiments for the detection of activated cas-
pases in whole-mounted brain preparations were done as
previously described16–18. Brieﬂy, brains from control and
treated 2 wpl animals were dissected out and immediately
incubated in 150 µL of phosphate buffered saline (PBS)
containing 1 μL of the 150× FLICA labelling solution at
37 °C for 1 h. Then, the brains were washed with PBS.
Brains were ﬁxed in 4% PFA in PBS for 2 h and 30 min
at 4 °C. Next, the brains were washed with PBS, mounted
on Superfrost Plus glass slides, and mounted with Mowiol.
Retrograde labelling of descending neurons with
regenerated axons
At 10 (morpholino treatments) or 12 (GABOB and
baclofen treatments) wpl, a second complete spinal cord
transection was performed 5mm below the site of the
original transection and the retrograde tracer Neurobiotin
(NB, 322.8 Da molecular weight; Vector; Burlingame, CA)
was applied to the spinal cord lesion with the aid of a
Minutien pin (#000). The animals were allowed to recover
at 19.5 °C with appropriate ventilation conditions for
7 days to allow the transport of the tracer from the
application point to the neuronal soma of identiﬁable
descending neurons (the M1, M2, M3, I1, I2, I3, I4, I5, B1,
B2, B3, B4, B5, B6 and Mth were analyzed; see Suppl.
Figure 2A). Since the original SCI also was a complete
spinal cord transection, only neurons whose axons
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regenerated at least 5 mm below the site of injury were
labelled by the tracer. Brains of these larvae were dissected
out, and the posterior and cerebrotectal commissures of
the brain were cut along the dorsal midline, and the alar
plates were deﬂected laterally and pinned ﬂat to a small
strip of Sylgard (Dow Corning Co., USA) and ﬁxed with
4% PFA in TBS for 4 h at room temperature. After washes
in TBS, the brains were incubated at room temperature
with Avidin D-FITC conjugated (Vector; Cat#: A-2001;
1:500) diluted in TBS containing 0.3% Triton X-100 for
2 days to reveal the presence of Neurobiotin. Brains were
rinsed in TBS and distilled water and mounted with
Mowiol.
Imaging and quantiﬁcations
An Olympus photomicroscope (AX-70; Provis) with a
20× Apochromatic 0.75 lens and equipped with a colour
digital camera (Olympus DP70, Tokyo, Japan) was used to
acquire images of brain sections from the in situ hybri-
dization experiments. Images were always acquired with
the same microscope and software settings. For the
quantiﬁcation of the level of gabab1 positive signal in
identiﬁable descending neurons, ﬁrst we established the
intensity rank of positive colorimetric in situ signal. For
this, we analyzed 10 random images from different des-
cending neurons of control and lesioned animals. The
“histogram” function in Image J shows the number of
pixels in each image in a range of intensity from 0 to 255.
With these images, we compared the intensity values in
regions with clear in situ signal and the intensity values in
regions without in situ signal. Based on this, we estab-
lished a value of 179 as the lower limit to consider the
colorimetric in situ signal as positive. Then the number of
pixels of positive in situ signal was quantiﬁed for each
section of each identiﬁed descending neuron. In brain
sections, the identiﬁcation of some of the speciﬁc des-
cending cells becomes more difﬁcult than in whole-
mounts. Thus, only the cells that were unequivocally
identiﬁed in at least two different sections were included
in the quantiﬁcations (the M1, M2, M3, I1, I3, I4, I5, B1,
B3, B4, B6 and Mth neurons; see Suppl. Figure 2A). Then,
we calculated the average number of positive pixels
per section for each individual neuron (see Table 1) and
these data were used for statistical analyses. The experi-
menter was blinded during quantiﬁcations.
The quantiﬁcation of the intensity of FLICA labelling
was done as previously described18. Brieﬂy, photo-
micrographs were acquired with a spectral confocal
microscope (model TCS-SP2; Leica, Wetzlar, Germany).
Images were always acquired under the same microscope
conditions for control or treated animals. Quantiﬁcation
of mean ﬂuorescent intensity (mean grey value) of each
identiﬁable neuron was done using the Fiji software. In
whole-mounted brain preparations, the speciﬁc
descending neurons are easily identiﬁable based on their
morphology and rostro-caudal and dorso-ventral anato-
mical location. The experimenter was blinded during
quantiﬁcations. The data from each individual identiﬁable
neuron (see Table 1) were used for statistical analyses.
The percentage of neurons with regenerated axons
(labelled by the Neurobiotin tracer) with respect to the
total number of analyzed neurons (see Table 1) was cal-
culated for each type of identiﬁable descending neuron
using an Olympus microscope or a Zeiss AxioImager Z2
microscope. The percentage of neurons with regenerated
axons with respect to the total number of analyzed neu-
rons in each animal was also calculated and these data
were used for statistical analyses. The experimenter was
blinded during quantiﬁcations. For the ﬁgures, images
were taken with the Olympus microscope or the spectral
confocal microscope (model TCS-SP2; Leica).
After quantiﬁcations, contrast and brightness were
minimally adjusted with Adobe Photoshop CS4 or CS6
(Adobe Systems, San José, CA, USA). Figure plates and
lettering were generated using Adobe Photoshop CS4 or
CS6 (Adobe Systems).
Statistical analyses
Statistical analysis was carried out using Prism 6
(GraphPad software, La Jolla, CA). Data were presented as
mean ± S.E.M. Normality of the data was determined only
when n numbers were higher than 10 by using the
D’Agostino-Pearson omnibus test, and the homo-
scedasticity was determined by the Brown-Forsythe test.
The in situ hybridization data that were normally dis-
tributed and homoscedastic were analyzed by a one-way
ANOVA. Post-hoc Dunnett’s multiple comparison tests
were used to compare pairs of data. In situ hybridization
data that were not normally distributed (or when the n
numbers were lower than 10) were analyzed by a
Kruskal–Wallis test and post-hoc Dunn’s multiple com-
parisons test. The results of control vs. treatment groups
were analyzed by a Student’s t-test (for normally dis-
tributed data) or a Mann–Whitney U test (for non-
normally distributed data). The in situ hybridization data
after morpholino application were analyzed by a
Mann–Whitney U test. The signiﬁcance level was set at
0.05. In the ﬁgures, signiﬁcance values were represented
by different number of asterisks: 1 asterisk (p value
between 0.01 and 0.05), 2 asterisks (p value between 0.001
and 0.01), 3 asterisks (p value between 0.0001 and 0.001)
and 4 asterisks (p value <0.0001).
Results
Increased expression of the gabab1 subunit in identiﬁable
descending neurons after SCI
GABAB receptors are obligate heterodimers formed
by gabab1 and gabab2 subunits49. In previous work, we
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reported the expression of the gabab1 and gabab2
receptor subunits in identiﬁable descending neurons of
adult sea lampreys under normal conditions42. Here, we
used gabab1 in situ hybridization ﬁrst to conﬁrm that
this receptor is also expressed in identiﬁable descending
neurons of mature larval sea lampreys (Suppl. Figure 2B;
Fig. 1a, c, e) and then to quantify changes in its
expression after SCI (Fig. 1a–g; Suppl. Figure 3). The
M1, M2, M3, I1, I3, I4, I5, B1, B3, B4, B6 and Mth
neurons were included in the analyses (see Material and
Methods). This revealed a signiﬁcant increase in the
expression of the gabab1 subunit in the M2 (ANOVA, p
= 0.0049), M3 (ANOVA, p= 0.002), I1 (Kruskal–Wallis,
p= 0.0009), I3 (Kruskal–Wallis, p= 0.0097), B1
(Kruskal–Wallis, p= 0.015) and B3 (Kruskal–Wallis, p
= 0.0178) neurons (Fig. 1g; Table 2) in 1 wpl animals as
compared to control unlesioned animals. Subsequent
power calculations (using 80% power) indicated that the
sample sizes were appropriately powered. Although a
similar trend was observed for the M1, I4, I5, B4, B6 and
Mth neurons in 1 wpl animals as compared to control
unlesioned animals, statistical analyses did not reveal
signiﬁcant changes in the expression of the
gabab1 subunit in these neurons (Suppl. Figure 3;
Table 2). At 4 wpl, the expression of the gabab1 subunit
was not signiﬁcantly different to control unlesioned
animals in all identiﬁable descending neurons and
returned to control levels (Fig. 1g; Suppl. Figure 3;
Table 2). This shows that the complete SCI induced an
acute increase in the expression of the gabab1 subunit in
descending neurons, which, together with the accumu-
lation of GABA around the axons of identiﬁable neu-
rons37, supports the possible role of endogenous GABA
as a neuroprotective and pro-regenerative molecule
after SCI in lampreys.
GABA and baclofen treatments inhibit caspase activation
in descending neurons after SCI
To test our hypothesis, we ﬁrst analyzed the effect of
GABA and baclofen (GABAB agonist) treatments in
caspase activation in identiﬁable descending neurons after
a complete SCI using FLICA labelling (Fig. 2a–i). As
previously shown, in control lesioned animals, there is a
statistically signiﬁcant correlation between the intensity of
FLICA labelling and the long-term survival and regen-
erative abilities of identiﬁable neurons (not shown;18,50).
At 2 wpl, animals treated with GABA or baclofen during
4 days showed a signiﬁcant inhibition of caspase activa-
tion (ﬂuorescence intensity of FLICA labelling) in iden-
tiﬁable descending neurons as compared to control
animals (GABA: Student’s t-test, p < 0.0001; baclofen:
Student’s t-test, p < 0.0001; Fig. 2j, k). This suggests that
GABA can inhibit apoptosis in descending neurons after
SCI by activating GABAB receptors.
GABOB and baclofen long-term treatments promote
axonal regeneration in descending neurons after SCI
Then, we studied the long-term effect of increasing
GABAergic signalling in axonal regeneration after a
complete SCI. Retrograde neuronal tract-tracing with
Neurobiotin showed that a treatment with either
GABOB (Fig. 3) or baclofen (Fig. 4) during 12 weeks
post-lesion signiﬁcantly promoted axonal regeneration
of identiﬁable descending neurons after a complete SCI
as compared to control animals (GABOB: Student’s t-
test, p= 0.0129 (Fig. 3h); baclofen: Mann–Whitney U
test, p= 0.0004 (Fig. 4h)). The baclofen used in these
experiments (from Carbosynth) was also tested to con-
ﬁrm that it had the same effect in the activation of
caspases as the baclofen acquired from Molekula. This
baclofen also inhibited caspase activation signiﬁcantly
in identiﬁable descending neurons as compared to
control animals in a different set of experiments
(Mann–Whitney U test, p < 0.0001; not shown). This
shows that an increase in GABAergic signalling through
GABAB receptors promotes axonal regeneration after a
complete SCI.
Endogenous GABA signalling through GABAB receptors
promotes axonal regeneration after SCI
To test whether endogenous GABA also promotes
regeneration by activating GABAB receptors, we decided
to use morpholinos to knockdown the expression of the
gabab1 subunit in descending neurons after a complete
SCI (Fig. 5). First, we used in situ hybridization to conﬁrm
that the active gabab1 morpholino is able to knockdown
the expression of the gabab1 mRNA in identiﬁable neu-
rons of 2 wpl animals (Fig. 5a–e). As an example, we
analyzed the M1 (Fig. 5a, b) and the I1 neurons (Fig. 5c,
d). The active gabab1 morpholino was able to signiﬁcantly
knockdown the expression of the gabab1 mRNA in
identiﬁable descending neurons as compared to the
gabab1 mismatch control morpholino (M1:
Mann–Whitney U test, p= 0.0111; I1: Mann–Whitney U
test, p= 0.0057; Fig. 5e). Then, neuronal tract-tracing
showed that the treatment with the active gabab1 mor-
pholino signiﬁcantly inhibited axonal regeneration of
identiﬁable descending neurons 10 weeks after a complete
SCI as compared to the animals treated with the gabab1
mismatch control morpholino (Mann–Whitney U test, p
= 0.0133; Fig. 5f–m). This conﬁrms that, in lampreys,
endogenous GABA promotes axonal regeneration of
descending neurons after a complete SCI by activating
GABAB receptors.
Discussion
Here, we have provided gain and loss of function data,
using pharmacological and genetic treatments, showing
that endogenous GABA signalling through GABAB
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receptors promotes neuronal survival and axonal regen-
eration of identiﬁable descending neurons of lampreys
after a complete SCI.
The analysis of the changes of expression of the
gabab1 subunit in response to a complete SCI revealed a
signiﬁcant increase in the expression of this subunit in
Fig. 1 Changes in the expression of the gabab1 subunit in identiﬁable descending neurons after a complete SCI. a, c and e
Photomicrographs of transverse sections of the brain showing the expression of the gabab1 transcript in descending neurons of control animals. b, d
and f Photomicrographs of transverse sections of the brain showing the expression of the gabab1 transcript in descending neurons of lesioned
animals at 1 wpl. g Graphs showing signiﬁcant changes (asterisks) in the number of gabab1 positive pixels per section of the soma of identiﬁable
descending neurons. The mean ± S.E.M. values are provided in Table 2. Scale bars: 20 µm
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some identiﬁable descending neurons (with other neurons
showing a similar trend). As stated in the introduction,
massive glutamate release and the subsequent activation
of glutamate receptors lead to an increase in Ca2+ inﬂux
into cells, which causes excitotoxicity and neuronal death
after SCI21,22,24,51; see52. GABAB receptors can cause the
inactivation of voltage-dependent Ca2+ channels (see32).
Therefore, this increase in the expression of GABAB
receptors could compensate for the inﬂux of Ca2+ into
axotomized descending neurons caused by massive glu-
tamate release. The acute increase in the expression of the
gabab1 subunit in descending neurons and the massive
release of GABA after SCI37 appears as one of the
mechanisms favouring neuronal survival and axonal
regeneration after SCI in lampreys. As far as we are aware,
no study has analyzed the expression of gabab subunits
after SCI in mammals. Only a few mammalian studies
have looked at changes in the expression of this receptor
following other types of nervous system injuries (sciatic
nerve ligation:53; traumatic brain injury:54; ulnar nerve
transection:55; cerebral ischaemia:56). In contrast to the
present results in lampreys, these studies showed that the
expression of GABAB receptors decreases after the injury
in different regions of the brain54–56. This could be a key
difference between regenerating and non-regenerating
animals, since axons of the later do not show
good regenerative abilities after CNS injuries. Interest-
ingly, and in agreement with the results in lampreys,
Huang and colleagues56 reported that an elevation in
the protein expression of GABAB receptors in the
cerebral cortex promotes neuroprotection after ischaemic
damage.
There is some controversy on the topic of whether
descending neurons of the brain of mammals die after SCI.
Some studies have shown the death of brain neurons after
SCI57–63. On the other hand, two recent reports did not
ﬁnd evidence of the death of corticospinal neurons after
SCI64,65, and suggested that these neurons only suffer
atrophy but do not die65. In any case, the death or atrophy
of descending neurons of mammals appears to involve
apoptotic mechanisms as shown by the appearance of
TUNEL labelling and activated caspase-3 immunor-
eactivity in these neurons after the injury at spinal levels60–
62. Recent work in lampreys has also shown that identiﬁ-
able descending neurons known to be “bad regenerators”
are actually “poor survivors” after a complete SCI8,12,14,50.
These neurons enter in a process of slow and delayed
death after SCI8,12–18 that is initiated by caspase activation
in the injured axon at spinal levels17,18. The death of these
neurons also occurs through apoptotic mechanisms as
shown by the appearance of activated caspases15–18,
TUNEL labelling14,15 and Fluoro-Jade® C labelling12,18.
Recent results have shown that there is a signiﬁcant cor-
relation between the intensity of caspase activation 2 wpl
and the long-term regenerative18 and survival50 abilities of
identiﬁable descending neurons of lampreys after SCI.
Present results indicate that the activation of GABAB
receptors by GABA/baclofen can inhibit caspase activation
after SCI in identiﬁable descending neurons, which is a key
step to preventing the development of apoptosis and
promoting neuronal survival. Previous work in other
models of CNS injury also showed that a baclofen treat-
ment can inhibit caspase activation (model of kainic-acid-
induced seizure in rats:29; models of ischaemic brain injury
Table 2 Mean ± S.E.M. values of the number of gabab1 positive in situ pixels/section in identiﬁable descending neurons
of control and injured animals
Gabab1 positive pixels/section Control 1 wpl 4 wpl
M1 258,170 ± 86,006 320,350 ± 78,104 148,657 ± 43,920
M2 237,552 ± 61,602 618,158 ± 176,397 131,367 ± 19,089
M3 144,448 ± 56,162 423,439 ± 93,059 85,245 ± 16,702
I1 140,858 ± 94,768 627,179 ± 137,246 176,392 ± 74,810
I3 39,783 ± 17,599 204,914 ± 49,099 61,945 ± 34,492
I4 68,678 ± 11,645 147,613 ± 44,903 45,723 ± 7,610
I5 37,027 ± 21,463 62,221 ± 13,380 54,634 ± 23,587
B1 198,893 ± 57,286 429,418 ± 43,503 202,694 ± 75,156
B3 184,112 ± 51,392 488,947 ± 86,189 161,864 ± 70,596
B4 183,470 ± 49,454 317,944 ± 79,980 274,012 ± 88,414
B6 222,515 ± 105,034 456,303 ± 87,734 273,466 ± 101,442
Mth 201,230 ± 84,794 395,530 ± 90,345 139,834 ± 31,750
Refers to Fig. 1 and Suppl. Figure 2
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in rats:27,31; model of chemical hypoxia in retinal ganglion
cells in rats:66). Our study shows that the activation of
GABAB receptors can also prevent apoptosis after a
traumatic SCI.
Of major importance is the fact that our results also
support the role of GABA as a molecule that promotes
true axonal regeneration of descending neurons through
the site of a complete SCI. Behavioural analyses were not
performed to establish a relationship between increased
regeneration and improved functional recovery after the
treatments. First, because in our case, control animals
usually reach the highest level of recovery when using the
Fig. 2 GABOB and baclofen treatments inhibit caspase activation in identiﬁable descending neurons. a, d and g Photomicrographs of whole-
mounted brains showing identiﬁable descending neurons with intense FLICA labelling in control animals. b, e and h Photomicrographs of whole-
mounted brains showing identiﬁable descending neurons with a reduction in FLICA labelling in GABA-treated animals. c, f and i Photomicrographs
of whole-mounted brains showing identiﬁable descending neurons with a reduction in FLICA labelling in baclofen-treated animals. j Graph showing
signiﬁcant changes (asterisks) in the level of caspase activation (intensity of ﬂuorescent FLICA labelling) after the GABA treatment. k Graph showing
signiﬁcant changes (asterisks) in the level of caspase activation (intensity of ﬂuorescent FLICA labelling) after the baclofen treatment. Rostral is up in
all photomicrographs. Scale bars: 100 µm
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Fig. 3 A long-term GABOB treatment promotes axonal regeneration of identiﬁable descending neurons. a, c and e Photomicrographs of
whole-mounted brains showing different reticulospinal populations with regenerated identiﬁable neurons in control animals, as identiﬁed by
retrograde labelling. b, d and f Photomicrographs of whole-mounted brains showing different reticulospinal populations with an increased number
of labelled (regenerated) identiﬁable neurons in treated animals. g Graph showing the percentage of regenerated neurons (with respect to the total
number of analyzed neurons) for each identiﬁable cell in control and GABOB-treated animals. h Graph showing signiﬁcant changes (asterisks) in the
percentage of regenerated neurons per animal after the GABOB treatment (control: 37.27 ± 3.33%; GABOB: 49.79 ± 4.16%). Arrows indicate
descending neurons that regenerated in GABOB-treated animals but not in controls animals. Rostral is up in all photomicrographs. Scale bars: 50 µm
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Fig. 4 A long-term baclofen treatment promotes axonal regeneration of identiﬁable descending neurons. a, c and e Photomicrographs of
whole-mounted brains showing different reticulospinal populations with regenerated identiﬁable neurons in control animals. b, d and f
Photomicrographs of whole-mounted brains showing different reticulospinal populations with an increased number of labelled (regenerated)
identiﬁable neurons in treated animals. g Graph showing the percentage of regenerated neurons (with respect to the total number of analyzed
neurons) for each identiﬁable cell in control and baclofen-treated animals. h Graph showing signiﬁcant changes (asterisks) in the percentage of
regenerated neurons per animal after the baclofen treatment (control: 46.17 ± 7.15%; baclofen: 77.91 ± 3.56%). Arrows indicate descending neurons
that regenerated in baclofen-treated animals but not in controls animals. Rostral is up in all photomicrographs. Scale bars: 100 µm
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Fig. 5 (See legend on next page.)
Romaus-Sanjurjo et al. Cell Death and Disease  (2018) 9:663 Page 12 of 15
Ofﬁcial journal of the Cell Death Differentiation Association
Ayers test (see ref.39) and also because the treated animals
were in the drugs until the day of analysis. Experiments
using a gabab1 morpholino demonstrated that endogen-
ous GABA acts as a pro-regenerative factor after SCI by
activating GABAB receptors. The morpholino experi-
ments suggest that GABA might promote regeneration by
activating GABAB receptors expressed in the axotomized
descending neurons. But, we cannot rule out the possi-
bility that GABA could also promote the regeneration of
descending neurons indirectly by inhibiting other cells
expressing GABAB receptors, like intrinsic spinal cord
neurons39,42 that could have also taken the morpholino in
our experiments. Our data agree with previous in vitro or
developmental studies regarding the role of GABA and
GABAB receptors in neurite outgrowth67. López-Bendito
and coworkers67 showed that the GABAB antagonist
CGP52432 decreases the length of the leading process in
migrating inhibitory neurons in brain slice cultures of
mice. Also, both GABA and baclofen stimulate retinal
ganglion neurite outgrowth in Xenopus cultures, and the
GABAB antagonist CGP54262 shortened the developing
optic projection in vivo68. But, as far as we are aware, our
results are the ﬁrst in vivo demonstration showing that
GABA promotes axonal regrowth after a CNS injury by
activating GABAB receptors. Present and previous37
results indicate that the GABAergic system of lampreys
responds successfully to a SCI to limit retrograde
degeneration and promote the regeneration of descending
pathways.
Conclusion
We have revealed a major role of GABA and GABAB
receptors in promoting the survival and regeneration of
individually identiﬁable descending neurons of lampreys
following a complete SCI. Now, it would be of interest to
decipher the underlying mechanisms behind the neuro-
protective and pro-regenerative effect of GABA. Based on
previous results in lampreys showing a negative effect of
Ca2+ in neurite outgrowth35,36, a decrease in Ca2+ levels
due to the activation of GABAB receptors could be one of
the key events in the inhibition of apoptosis and activation
of axonal regeneration by GABA. In future studies, it
might be also interesting to analyze changes in gene
expression elicited by GABA signalling and the activation
of GABAB receptors to reveal new pathways involved in
axonal regeneration and neuronal survival in lampreys.
The present results provide further support for the idea
suggesting that the lesioned spinal cord is a “new spinal
cord”69 and the importance of understanding the changes
that occur after SCI in different neurotransmitter systems
in the brain and in the spinal cord above and below the
site of injury. This study adds to previous work revealing
anatomical37–39,70,71 and physiological40,72,73 changes in
different neurotransmitter systems above and below the
lesion in recovered lampreys and highlights the impor-
tance of understanding these changes before applying
neuropharmacological interventions in SCI patients.
Specially, when drugs affecting neurotransmission might
not only modulate locomotor circuits, but also affect the
process of neuronal regeneration and recovery (e.g. ser-
otonin inhibitors/toxins: see refs.72,74; GABOB/baclofen:
present results).
Our results provide a strong basis to translate this
knowledge to mammalian models of SCI for the devel-
opment of new therapies for patients with SCI. A recent
large observational cohort study has found that the early
administration of gabapentinoids (which are administered
as anticonvulsants for SCI patients) improves motor
recovery following SCI75. Interestingly, baclofen is also
already in use in the clinic, even for the treatment of SCI
patients with spasticity76 or neuropathic pain77, which
could facilitate the clinical translation of similar results in
pre-clinical models of SCI.
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